Oireachtas Joint and Select Committees

Thursday, 22 October 2015

Public Accounts Committee

Health Service Executive Financial Statements 2014
2014 Annual Report and Appropriation Accounts of the Comptroller and Auditor General
Vote 39: Health Service Executive
Chapter 19: Compliance with Prompt Payment Legislation in the Health Sector
Chapter 20: Management of Private Patient Income in the Health Sector
Chapter 21: Control over the Supply of High-Tech Drugs and Medicines

10:00 am

Photo of Seán FlemingSeán Fleming (Laois-Offaly, Fianna Fail) | Oireachtas source

I will be satisfied if Mr. Dempsey sends a note.

There are one or two other small points. This will be an issue for Mr. Barry O'Brien in particular, because I refer to it in my opening comments. The second paragraph on page 46 states:

The HSE is currently involved in a legal dispute with a number of drugs importing companies with respect to the implementation of cost savings and other initiatives outlined as part of a framework agreement between the Irish Pharmaceutical Healthcare Association (IPHA), the Department of Health, and the HSE, which came into effect on 1 November 2012. The outcome from the dispute process based on the current stage of legal proceedings remains uncertain

and therefore there is difficulty in quantifying the amount of any potential liability which may arise. This leads me on to a question I mentioned in my opening comment to the effect that negotiations between what was the HSE and the IPHA on a new drugs contract were stopped or did not happen. They were proceeding, and many people thought they would be concluded in recent weeks, but that is not happening. I understand from the HSE that the Department of Public Expenditure and Reform is directly involved in this regard, and rightly so. Consequently, I wish to ask the representative of that Department why these formal negotiations have not commenced, because I understand the contract is up around now.

Comments

No comments

Log in or join to post a public comment.